This inventor holds 1 USPTO granted patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: The Innovations of Dong Won-Shik Kim
Introduction: Dong Won-Shik Kim is a notable inventor based in Rockville, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as A2A-receptor antagonists. His work is characterized by a commitment to advancing medical science through innovative solutions.
Latest Patents: Dong Won-Shik Kim holds 1 patent. His patent is directed to compounds of generic formula I, or pharmaceutically acceptable salts thereof, which are believed to be useful as an A2A-receptor antagonist. This invention showcases his expertise in medicinal chemistry and his dedication to improving therapeutic options.
Career Highlights: Throughout his career, Dong Won-Shik Kim has been associated with Merck Sharp & Dohme Corp., a leading global healthcare company. His role at Merck has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development.
Collaborations: Some of his notable coworkers include Amjad Ali and Rongze Kuang. Their collective efforts have fostered an environment of innovation and excellence within their projects.
Conclusion: Dong Won-Shik Kim's contributions to the field of pharmaceuticals exemplify the impact of dedicated inventors in advancing healthcare solutions. His work continues to inspire future innovations in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile